Nanocurcumin Enhances Antioxidant Defense through GPx Upregulation in Ovarian Granulosa Cells of Endometriosis Mouse Model

BACKGROUND: Endometriosis impairs female reproductive function through oxidative stress and apoptosis, reducing oocyte quality and causing infertility. Current therapies are limited by suboptimal efficacy and side effects, including ovulation suppression. Curcumin offers antioxidant and anti-inflammatory benefits but has low bioavailability and poor solubility, which can be improved through nanoparticle formulation. Although nanocurcumin is suggested to act through multiple pathways, its mechanisms remain unclear. This study was conducted to evaluate the antioxidant and anti-apoptotic effects of nanocurcumin in a mouse model of endometriosis.

Thirty-five mice were allocated into five groups and induced to develop endometriosis using cyclosporine A, ethinyl estradiol, and human endometrial tissue. Nanocurcumin was formulated at three particle sizes (3.71; 3.98; and 25.60 nm) and administered orally at doses of 50, 100, or 200 mg/kg/day for 14 days. After treatment, the mice were euthanized, and ovarian tissues were collected for immunohistochemical analysis of glutathione peroxidase (GPx) and B-cell lymphoma-2 (Bcl-2) expression.

The highest GPx expression was observed in the group receiving 50 mg/kg/day nanocurcumin (mean±SD= 6.31±1.97; p=0.042). The lowest expression of Bcl-2 was observed in control group with no treatment (mean±SD=4.15±2.48; p=0.582). Nanocurcumin administration significantly increased GPx expression in a dose-dependent manner compared with the untreated group, while no significant differences were found in Bcl-2 expression.

Nanocurcumin increases GPx expression, particularly at 50 mg/kg/day, indicating its potential as an antioxidant in reducing oxidative damage associated with endometriosis. However, nanocurcumin did not significantly influence Bcl-2 expression. These findings support nanocurcumin’s role as an effective antioxidant agent in protecting ovarian granulosa cells in endometriosis.

nanocurcumin, GPx, Bcl-2, endometriosis, granulosa cells Full Text: PDFReferences Ochoa Bernal MA, Fazleabas AT. The known, the unknown and the future of the pathophysiology of endometriosis. Int J Mol Sci. 2024; 25(11): 5815, CrossRef. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021; 397(10276): 839-52, CrossRef. Saragih CF, Rivany R, Sahil MF, Fadjrir F, Ardiansyah E, Yaznil MR, et al. The difference of Bax protein expression between endometrioma and ovarian carcinoma. Mol Cell Biomed Sci. 2019; 3(2): 95-9, CrossRef. Park W, Lim W, Kim M, Jang H, Park SJ, Song G, Park S. Female reproductive disease, endometriosis: From inflammation to infertility. Mol Cells. 2025; 48(1): 100164, CrossRef. Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020; 382(13): 1244-56, CrossRef. Zakiyah M, Asmarinah A. Mechanism of immune system dysfunction, apoptosis and oxidative stress on endometriosis. J Biomed Transl Res. 2023; 9(2): 88-95, CrossRef. Didziokaite G, Biliute G, Gudaite J, Kvedariene V. Oxidative stress as a potential underlying cause of minimal and mild endometriosis-related infertility. Int J Mol Sci. 2023; 24(4): 3809, CrossRef. Simopoulou M, Rapani A, Grigoriadis S, Pantou A, Tsioulou P, Maziotis E, et al. Getting to know endometriosis-related infertility better: A review on how endometriosis affects oocyte quality and embryo development. Biomedicines. 2021; 9(3): 273, CrossRef. Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria J Med. 2018; 54(4): 287-93, CrossRef. Meresman GF, Vighi S, Buquet RA, Contreras-Ortiz O, Tesone M, Rumi LS. Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril. 2000; 74(4): 760-6, CrossRef. Kunnumakkara AB, Hegde M, Parama D, Girisa S, Kumar A, Daimary UD, et al. Role of turmeric and curcumin in prevention and treatment of chronic diseases: Lessons learned from clinical trials. ACS Pharmacol Transl Sci. 2023; 6(4): 447-518, CrossRef. Bertoncini-Silva C, Vlad A, Ricciarelli R, Giacomo Fassini P, Suen VMM, Zingg JM. Enhancing the bioavailability and bioactivity of curcumin for disease prevention and treatment. Antioxidants. 2024; 13(3): 331, CrossRef. Sadeghi S, Lee WK, Kong SN, Shetty A, Drum CL. Oral administration of protein nanoparticles: An emerging route to disease treatment. Pharmacol Res. 2020; 158: 104685, CrossRef. Hestianah EP, Widjiati W, Ntoruru JM, Widyanugraha MYA. Administration of nanocurcumin in mice models of endometriosis as an effort to improve folliculogenesis. Biomed Pharmacol J. 2024; 17(2): 939-47, CrossRef. Van Bavel N, Issler T, Pang L, Anikovskiy M, Prenner EJ. A simple method for synthesis of chitosan nanoparticles with ionic gelation and homogenization. Molecules. 2023; 28(11): 4328, CrossRef. Atiken RJ. Implications for fertility. Reproduction. 2020; 159(4): R189-201, CrossRef. Immediata V, Ronchetti C, Spadaro D, Cirillo F, Levi-Setti PE. Oxidative stress and human ovarian response-from somatic ovarian cells to oocytes damage: A clinical comprehensive narrative review. Antioxidants. 2022; 11(7): 1335, CrossRef. Ong G, Logue SE. Unfolding the interactions between endoplasmic reticulum stress and oxidative stress. Antioxidants. 2023; 12(5): 981, CrossRef. Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Arch Toxicol. 2024; 98(5): 1323-67, CrossRef. Islam MR, Rauf A, Akash S, Trisha SI, Nasim AH, Akter M, et al. Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives. Biomed Pharmacother. 2024; 170: 116034, CrossRef. Sadoughi D, Edalatmanesh MA, Rahbarian R. Protective effect of curcumin on quality parameters of sperm and testicular tissue alterations in alloxan-induced diabetic rats as animal model. Indones Biomed J. 2019; 11(3): 240-6, CrossRef. Karthikeyan A, Senthil N, Min T. Nanocurcumin: A Promising Candidate for Therapeutic Applications. Front Pharmacol. 2020;11: 487, CrossRef. Sharifi-Rad J, Rayess Y El, Rizk AA, Sadaka C, Zgheib R, Zam W, et al. Turmeric and its major compound curcumin on health: Bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications. Front Pharmacol. 2020; 11: 01021, CrossRef. Silalahi T, Alwi I, Suyatna F, Sartika KD, Suwita CS. Curcumin's antioxidant properties in stable coronary artery disease patients undergoing percutaneous coronary intervention: A randomized controlled trial. Indones Biomed J. 2022; 14(1): 66-73, CrossRef. Ramírez-Mendoza AA, Ramírez-Herrera MA, Cortez-Álvarez CR, Nery-Flores SD, Tejeda-Martínez AR, Romero-Prado MM de J, et al. Curcumin modifies the activity of plasmatic antioxidant enzymes and the hippocampal oxidative profile in rats upon acute and chronic exposure to ozone. Molecules. 2022; 27(14): 4531, CrossRef. Fuloria S, Mehta J, Chandel A, Sekar M, Rani NNIM, Begum MY, et al. A comprehensive review on the therapeutic potential of Curcuma longa Linn. in relation to its major active constituent curcumin. Front Pharmacol. 2022; 13: 820806, CrossRef. Syarifah AS, Sudjarwo SA, Hendarto H, I'tishom R, Supriyanto. Nanocurcumin protective effect on Gpx scavenger enzyme expression and apoptosis of lead acetate-induced rats ovarian granulosa cells. J Int Dent Med Res. 2021; 14(1): 419-25, article. Qian S, Wei Z, Yang W, Huang J, Yang Y, Wang J. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol. 2022; 12: 985363, CrossRef. Cui J, Li H, Zhang T, Lin F, Chen M, Zhang G, et al. Research progress on the mechanism of curcumin anti-oxidative stress based on signaling pathway. Front Pharmacol. 2025; 16: 1548073, CrossRef. Sarawi WS, Alhusaini AM, Fadda LM, Alomar HA, Albaker AB, Aljrboa AS, et al. Curcumin and nano-curcumin mitigate copper neurotoxicity by modulating oxidative stress, inflammation, and akt/gsk-3β signaling. Molecules. 2021; 26(18): 5591, CrossRef. Moghiseh M, Mirzayan Shanjani S, Banaifar AA, Kazemzadeh Y, Sedaghati S. The effect of aerobic training and nanomicelle curcumin supplementation on MDA and BAX and BCL-2 activity levels on cardiotoxicity of mice infected with breast cancer in the phase of mani with doxorubicin. J Zabol Med Sch. 2023; 6(2): 71-82, CrossRef. Zhao L, Gu Q, Xiang L, Dong X, Li H, Ni J, et al. Curcumin inhibits apoptosis by modulating Bax/ Bcl-2 expression and alleviates oxidative stress in testes of streptozotocin-induced diabetic rats. Ther Clin Risk Manag. 2017; 13: 1099-105, Zhao Y, Zhang Y, Liu D, Feng H, Wang X, Su J, et al. Identification of curcumin as a novel potential drug for promoting the development of small ovarian follicles for infertility treatment. PNAS Nexus. 2022; 1(3): pgac108, CrossRef. DOI: https://doi.org/10.18585/inabj.v17i6.3846 Copyright (c) 2025 The Prodia Education and Research Institute This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Indexed by: The Prodia Education and Research Institute